ArticleFrontiers in medicine2025
An explainable deep learning-based feature fusion model for acute lymphoblastic leukemia diagnosis and severity assessment.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- AI-driven saliency-guided retinal vessel segmentation framework for sustainable digital pathology.Frontiers in medicine · 2026Article
- Recent advances in deep learning for leukemia diagnosis: a scoping review of diagnostic modalities and fusion-based approaches.Frontiers in digital health · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute lymphoblastic leukemia (ALL) is a malignant blood disorder that primarily affects white blood cells, particularly in children, where early and accurate diagnosis is critical for effective treatment and recovery. This study introduces a novel deep learning framework, termed XIncept-ALL, for automated detection and classification of ALL severity levels. The model integrates pre-trained InceptionV3 and Xception networks through feature fusion blocks, enabling robust representation learning. To enhance performance, data auto-augmentation techniques were applied to address class imbalance and reduce overfitting. Furthermore, Grad-CAM visualizations were employed to highlight discriminative regions of ALL cell images, providing interpretability of the model's predictions and validating that the network focuses on clinically relevant features. The proposed system was evaluated using a newly developed private dataset, Pak-ALL, collected from Pakistani hospitals, along with additional datasets from reliable web sources. Extracted features were classified using an XGBoost classifier into four categories: Benign, Early, Pre, and Pro. Extensive experiments demonstrated the superior performance of the proposed framework, achieving an average accuracy of 99.5% on a challenging external dataset (Iranian dataset). The results highlight the efficiency, scalability, and practicality of the XIncept-ALL model for medical image analysis. By offering both improved classification accuracy and interpretable decision support via Grad-CAM, the proposed approach represents a significant advancement toward reliable computer-aided diagnostic systems for ALL, with strong potential to support clinical decision-making and improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.